Education
About Us
Working with TipRanks
Follow Us
89Bio Inc (ETNB)
:ETNB
Total Valuation
89bio has a market cap or net worth of ―. The enterprise value is ―.
Market Cap―
Enterprise Value―
Share Statistics
89bio has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding―
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
89bio’s return on equity (ROE) is -0.92 and return on invested capital (ROIC) is -86.94%.
Return on Equity (ROE)-0.92
Return on Assets (ROA)-0.77
Return on Invested Capital (ROIC)-86.94%
Return on Capital Employed (ROCE)-0.87
Revenue Per Employee―
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of 89bio is ―. 89bio’s PEG ratio is -0.03.
PE Ratio―
PS Ratio0.00
PB Ratio2.04
Price to Fair Value2.04
Price to FCF-2.23
Price to Operating Cash Flow-2.90
PEG Ratio-0.03
Income Statement
In the last 12 months, 89bio had revenue of 0.00 and earned -367.08M in profits. Earnings per share was -3.51.
Revenue0.00
Gross Profit-38.00K
Operating Income-384.66M
Pretax Income-366.39M
Net Income-367.08M
EBITDA-384.66M
Earnings Per Share (EPS)-3.51
Cash Flow
In the last 12 months, operating cash flow was -439.10M and capital expenditures -87.00K, giving a free cash flow of -439.19M billion.
Operating Cash Flow-439.10M
Free Cash Flow-439.19M
Free Cash Flow per Share-10.00T>
Dividends & Yields
89bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta―
52-Week Price Change86.90%
50-Day Moving Average12.41
200-Day Moving Average9.75
Relative Strength Index (RSI)76.94
Average Volume (3m)―
Important Dates
89bio upcoming earnings date is Nov 6, 2025, After Close (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend Date―
Financial Position
89bio as a current ratio of 13.19, with Debt / Equity ratio of 0.28%
Current Ratio13.19
Quick Ratio13.19
Debt to Market Cap0.04
Net Debt to EBITDA0.23
Interest Coverage Ratio-101.57
Taxes
In the past 12 months, 89bio has paid 692.00K in taxes.
Income Tax692.00K
Effective Tax Rate>-0.01
Enterprise Valuation
89bio EV to EBITDA ratio is -1.90, with an EV/FCF ratio of -1.99.
EV to Sales0.00
EV to EBITDA-1.90
EV to Free Cash Flow-1.99
EV to Operating Cash Flow-1.99
Balance Sheet
89bio has $561.16M in cash and marketable securities with $1.46M in debt, giving a net cash position of $559.70M billion.
Cash & Marketable Securities$561.16M
Total Debt$1.46M
Net Cash$559.70M
Net Cash Per Share$10.00T>
Tangible Book Value Per Share$3.83
Margins
Gross margin is -123.81%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-123.81%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for 89bio is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-82.75%